Collaborative Group on Epidemiological Studies of Ovarian Cancer. Ovarian cancer and body size: individual participant meta-analysis including 25,157 women with ovarian cancer from 47 epidemiological studies. PLoS Med 2012;9(4):e1001200. doi: 10.1371/journal.pmed.1001200.

Coogan PF, Kelly JP, Strom BL, Rosenberg L. Statin and NSAID use and prostate cancer risk. Pharmacoepidemiol Drug Saf 2010 doi:10.1002/pds.1970 (E-Pub). PMCID: PMC2906219.

Zhang Y, Coogan PF, Palmer JR, Strom BL, Rosenberg L. A case-control study of reproductive factors, female hormone use, and risk of pancreatic cancer. Cancer Causes Control 2009 doi:10.1007/s10552-009-9478-9 (E-Pub). PMCID: PMC2895493.

Coogan PF, Strom BL, Rosenberg L. Antidepressant Use and Colorectal Cancer Risk. Pharmacoepidemiol Drug Saf 2009 doi:10.1002/pds.1808 (E-Pub); 18(11):1111-14. PMCID: PMC2783290.

Zhang Y, Coogan PF, Palmer JR, Strom BL, Rosenberg L. Cancer Causes Control 2009 doi:10.1007/s10552-008-9282-y (E-Pub); 20(5):691-8. PMCID: PMC2755205.

Rosenberg L, Zhang Y, Coogan PF, Palmer JR. A Case-Control Study of Oral Contraceptive Use and Incident Breast Cancer. Am J Epidemiol 2009;169(4):473-479. PMCID: PMC2726644.

Coogan PF, Strom BL, Rosenberg L.  Diuretic Use and the Risk of Breast Cancer.  J Hum Hypertens 2009;23:216-219.

Collaborative Group on Epidemiological Studies of Ovarian Cancer (Coogan PC, Rosenberg L).  Ovarian cancer and oral contraceptives: Collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls.  Lancet 2008;371:303-14.

Coogan PF, Strom BL, Rosenberg L. SSRI use and breast cancer risk by hormone receptor status. Breast Cancer Res Treat 2008 doi:10.1007/s10549-007-9664-y (E-Pub);109(3):527-31.

Coogan PF, Rosenberg L, Strom BL. Statin use and the risk of 10 cancers. Epidemiology 2007;18:213-219.

Rosenberg L, Coogan PF, Palmer JR. Chapter 9: Case-control surveillance. Textbook of Pharmacoepidemiology (Strom BL, Kimmel SE, eds). New York: Wiley, 5th Edition, 2006:137-149.

Zhang Y, Coogan PF, Palmer JR, Strom BL, Rosenberg L.  Risk of non-Hodgkin’s lymphoma and use of non-steroidal anti-inflammatory drugs.  Cancer Detect Prev 2006;30(1):99-101.

Rosenberg L, Coogan PF, Palmer JR. Chapter 9: Case-control surveillance. Textbook of Pharmacoepidemiology (Strom BL, Kimmel SE, eds). New York: Wiley, 5 th Edition, 2006:137-149.

Coogan PF, Rosenberg L, Palmer JR, Strom BL, Zauber AG, Shapiro S. Statin use and the risk of breast and prostate cancer. Epidemiology 2002;13:262-7.

Blackman JA, Coogan PF, Rosenberg L, Strom BL, Zauber AG, Palmer JR, Langenberg P, Shapiro S. Estrogen replacement therapy and risk of lung cancer by cell type. Pharmacoepidemiol Drug Saf 2002;11:561-567.

Coogan P, Rosenberg L. Response to Etminan letter Re: Statin use and the risk of breast and prostate cancer. [Letter] Epidemiology, 2002;13:607-8.

Coogan PF, Rosenberg L, Palmer JR, Strom BL, Zauber AG, Stolley PD, Shapiro S. Nonsteroidal anti-inflammatory drugs and risk of digestive cancers at sites other than the large bowel. Cancer Epidemiol Biomarkers Prev 2000;9:119-23.

Coogan PF, Rosenberg L, Louik C, Zauber AG, Stolley PD, Strom BL, Shapiro S. NSAIDs and risk of colorectal cancer according to presence or absence of family history of the disease. Cancer Causes Control 2000;11:249-55.

Shapiro S. Chapter 13: Case-Control Surveillance. In: Strom BL, ed. Pharmacoepidemiology. 3 rd Edition. Chichester , UK : John Wiley and Sons, 2000:209-30.

Rosenberg L, Palmer JR, Rao RS, Coogan PF, Strom BL, Zauber AG, Stolley PD, Shapiro S. A case-control study of analgesic use and ovarian cancer. Cancer Epidemiol Biomarkers Prev 2000;9:933-7.

Coogan PF, Rosenberg L, Palmer JR, Strom BL, Stolley PD, Zauber AG, Shapiro S. Risk of ovarian cancer according to use of antidepressants, phenothiazines, and benzodiazepines ( United States). Cancer Causes Control 2000;11:839-45.

Coogan PF, Rosenberg L, Palmer JR, Strom BL, Zauber AG, Stolley PD, Shapiro S. Phenolphthalein laxatives and risk of cancer. J Natl Cancer Inst 2000;92:1943-4.

Rosenberg L, Rao RS, Palmer JR, Strom BL, Zauber A, Warshauer ME, Stolley PD, Shapiro S. Transitional cell cancer of the urinary tract and renal cell cancer in relation to acetaminophen use (United States). Cancer Causes Control 1998;9:83-8.

Rosenberg L, Rao RS, Palmer JR, Strom BL, Stolley PD, Zauber AG, Warshauer ME, Shapiro S. Calcium channel blockers and the risk of cancer. JAMA 1998;279:1000-4.

Rosenberg L, Stephenson WP, Rao RS, Palmer JR, Strom BL, Shapiro S. The diagnosis of renal cell cancer in relation to hypertension ( United States). Cancer Causes Control 1998;9:611-14.

Rosenberg L, Palmer JR, Rao RS, Zauber AG, Strom BL, Warshauer ME, Harlap S, Shapiro S. Case-control study of oral contraceptive use and risk of breast cancer. Am J Epidemiol 1996;143:25-37.

Zhang Y, Rosenberg L, Colton T, Cupples LA, Palmer JR, Strom BL, Zauber AG, Warshauer ME, Harlap S, Shapiro S. Adult height and risk of breast cancer among white women in a case-control study. Am J Epidemiol 1996;143:1123-8.

Palmer JR, Rosenberg L, Harlap S, Strom BL, Warshauer ME, Zauber AG, Shapiro S. Adult height and risk of breast cancer among US black women. Am J Epidemiol 1995;141:845-9.

Rosenberg L. Nonsteroidal anti-inflammatory drugs and cancer. Prev Med 1995;24:107-9.

Rosenberg L, Palmer JR, Zauber AG, Warshauer ME, Strom BL, Harlap S, Shapiro S. Relation of benzodiazepine use to the risk of selected cancers: Breast, large bowel, malignant melanoma, lung, endometrium, ovary, non-Hodgkins lymphoma, testis, Hodgkin's disease, thyroid and liver. Am J Epidemiol 1995;141:1153-60.

Palmer JR, Rosenberg L, Rao RS, Strom BL, Warshauer ME, Harlap S, Zauber A, Shapiro S. Oral contraceptive use and breast cancer risk among African-American women. Cancer Causes Control 1995;6:321-31.

Issaragrisil S, Kaufman DW, Anderson TE, Chansung K, Thamprasit T, Sirijirachai J, Piankijagum A, Porapakham Y, Vannasaeng S, Leaverton PE, Shapiro S, Young NS, and the Aplastic Anemia Study Group. An association of aplastic anemia in Thailand with low socioeconomic status. Br J Haematol 1995;91:80-4.

Rosenberg L, Palmer JR, Zauber AG, Warshauer ME, Lewis JL Jr, Strom BL, Harlap S, Shapiro S. A case-control study of oral contraceptive use and invasive epithelial ovarian cancer. Am J Epidemiol 1994;139:654-61.

Shapiro S. Case-control Surveillance. In: Strom BL, ed. Pharmacoepidemiology. 2nd ed. Chichester , UK : John Wiley and Sons, 1994:301-22.

Rosenberg L, Palmer JR, Zauber AG, Warshauer ME, Strom BL, Harlap S, Shapiro S. The relation of vasectomy to the risk of cancer. Am J Epidemiol 1994;140:431-8.

Palmer JR, Rosenberg L, Strom BL, Harlap S, Zauber AG, Warshauer ME, Shapiro S. Oral contraceptive use and risk of cutaneous malignant melanoma. Cancer Causes Control 1992;3:547-54.

Kaufman DW, Palmer JR, Rosenberg L, Shapiro S. Oestrogen replacement therapy and breast cancer: new results from the Slone Epidemiology Unit's Case-Control Surveillance Study. In: Mann RD , ed. Hormone replacement therapy and breast cancer risk. Park Ridge , NJ : The Parthenon Publishing Group, 1992;173-84.

Rosenberg L, Palmer JR, Zauber AG, Warshauer ME, Stolley PD, Shapiro S. A hypothesis: Nonsteroidal anti-inflammatory drugs reduce the incidence of large bowel cancer. J Natl Cancer Inst 1991;83:355-8.

Lesko SM, Rosenberg L, Kaufman DW, Stolley PD, Warshauer ME, Lewis JL, Shapiro S. Endometrial cancer and age at last delivery: evidence of an association. Am J Epidemiol 1991;133:554-9.

Kelly JP, Rosenberg L, Kaufman DW, Shapiro S. Reliability of personal interview data in a hospital-based case-control study. Am J Epidemiol 1990;131:79-90.

Kaufman DW, Werler MM, Palmer JR, Rosenberg L, Stolley PD, Warshauer ME, Clarke EA, Miller DR, Shapiro S. Diazepam use in relation to breast cancer: results from two case-control studies. Am J Epidemiol 1990;131:483-90.

Rosenberg L, Palmer JR, Zauber AG, Warshauer ME, Stolley PD, Shapiro S. Vasectomy and the risk of prostate cancer. Am J Epidemiol 1990;132:1051-5.

Austin KL, Palmer JR, Seddon JM, Glynn RJ, Rosenberg L, Gragoudas ES, Kaufman DW, Shapiro S. Case-control study of idiopathic retinal detachment. Int J Epidemiol 1990;19:1045-9.

Miller DR . Breast cancer and early oral contraceptive use: studies from the Slone Epidemiology Unit. In: Mann RD, ed. Oral contraceptives and breast cancer. Park Ridge , NJ : The Parthenon Publishing Group, 1990:137-57.

Rosenberg L, Palmer JR, Shapiro S. Oral contraceptive use in relation to the risk of breast cancer: the data of the Slone Epidemiology Unit in women aged 45-59 years. In: Mann RD , ed. Oral contraceptives and breast cancer. Park Ridge , NJ : The Parthenon Publishing Group, 1990:159-68.

Shapiro S, Rosenberg L. The need for future studies of breast cancer risk in relation to oral contraceptive use: a comprehensive strategy. In: Mann RD , ed. Oral contraceptives and breast cancer. Park Ridge , NJ : The Parthenon Publishing Group, 1990:373-94.

Palmer JR. Oral contraceptive use and gestational choriocarcinoma. Cancer Detect Prev 1990; 15:45 -8.

Miller DR, Rosenberg L, Kaufman DW, Stolley P, Warshauer ME, Shapiro S. Breast cancer before age 45 and oral contraceptive use: new findings. Am J Epidemiol 1989;129:269-80.

Kaufman DW, Palmer JR, Rosenberg L, Stolley P, Warshauer E, Shapiro S. Tar content of cigarettes in relation to lung cancer. Am J Epidemiol 1989;129:703-11.

Kaufman DW, Kelly JP, Rosenberg L, Stolley PD, Warshauer ME, Shapiro S. Hydralazine use in relation to cancers of the lung, colon, and rectum. Eur J Clin Pharmacol 1989;36:259-64.

Rosenberg L, Palmer JR, Shapiro S. Gestational trophoblastic disease and use of oral contraceptives. [Letter to the Editor] Am J Obstet Gynecol 1989;161:1087-8.

Rosenberg L, Werler MM, Palmer JR, Kaufman DW, Warshauer ME, Stolley PD, Shapiro S. The risks of cancers of the colon and rectum in relation to coffee consumption. Am J Epidemiol 1989;130:895-903.

Palmer JR, Rosenberg L, Kaufman DW, Warshauer ME, Stolley P, Shapiro S. Oral contraceptive use and liver cancer. Am J Epidemiol 1989;130:878-82.

Kaufman DW, Kelly JP, Welch WR, Rosenberg L, Stolley PD, Warshauer ME, Lewis J, Woodruff J, Shapiro S. Noncontraceptive estrogen use and epithelial ovarian cancer. Am J Epidemiol 1989;130:1142-51.

Levy M, Miller D, Kaufman D, Siskind V, Schwingl P, Rosenberg L, Strom B, Shapiro S. Major upper gastrointestinal bleeding and the use of aspirin and other nonnarcotic analgesics. Arch Intern Med 1988;148:281-5.

Rosenberg L, Palmer JR, Kaufman DW, Strom BL, Schottenfeld D, Shapiro S. Breast cancer in relation to the occurrence and time of induced and spontaneous abortion. Am J Epidemiol 1988;127:981-9.

Shapiro S. Case-control studies of acute and long-term adverse effects. In: WHO Anniversary Symposium. Adverse drug reactions. A global perspective. WHO Collaborating Centre for International Drug Monitoring. Department of Drugs, National Board of Health and Welfare. University of Uppsala , Sweden. September 22-23, 1988:51-5.

Helmrich SP, Rosenberg L, Kaufman DW, Strom B, Shapiro S. Venous thromboembolism in relation to oral contraceptive use. Obstet Gynecol 1987;69:91-5.

Kaufman DW, Kelly JP, Rosenberg L, Stolley PD, Schottenfeld D, Shapiro S. Hydralazine and breast cancer. J Natl Cancer Inst 1987;78:243-6.

Schatzkin A, Palmer JR, Rosenberg L, Helmrich SP, Miller DR, Kaufman DW, Lesko SM, Shapiro S. Risk factors for breast cancer in black women. J Natl Cancer Inst 1987;78:213-17.

Miller DR, Rosenberg L, Kaufman DW, Helmrich SP, Schottenfeld D, Lewis J, Stolley PD, Rosenshein N, Shapiro S. Epithelial ovarian cancer and coffee drinking. Int J Epidemiol 1987;16:13-17.

Rosenberg L, Lesko SM. Cigarette smoking and endometrial cancer. In: Rosenberg MJ, ed. Smoking and reproductive health. Littleton , MA : PSG Publishing Company, Inc., 1987:160-6.

Lesko SM, Rosenberg L, Kaufman DW, Helmrich SP, Miller DM, Strom B, Schottenfeld D, Rosenshein NB, Knapp RC, Lewis J, Shapiro S. Cigarette smoking and the risk of endometrial cancer. N Engl J Med 1985;313:593-6.

Rosenberg L, Miller DR, Helmrich SP, Kaufman DW, Schottenfeld D, Stolley PD, Shapiro S. Breast cancer and the consumption of coffee. Am J Epidemiol 1985;122:391-9.

Lesko SM, Kaufman DW, Rosenberg L, Helmrich SP, Miller DR, Stolley PD, Shapiro S. Evidence of increased risk of Crohn's disease in oral contraceptive users. Gastroenterology 1985;89:1046-9.

Shapiro S, Parsells JL, Rosenberg L, Kaufman DW, Helmrich SP, Rosenshein N, Lewis J, Knapp R, Stolley PD, Schottenfeld D. Risk of localized and widespread endometrial cancer in relation to recent and discontinued use of conjugated estrogens. N Engl J Med 1985;313:969-72.

Rosenberg L. Post-marketing surveillance: The approach of the Drug Epidemiology Unit. Drug Inf J 1985;19:263-8.

Rosenberg L, Schwingl PJ, Kaufman DW, Miller DR, Helmrich SP, Stolley PD, Schottenfeld D, Shapiro S. Breast cancer and cigarette smoking. N Engl J Med 1984;310:92-4.

Rosenberg L, Miller DR, Kaufman DW, Helmrich SP, Stolley PD, Schottenfeld D, Shapiro S. Breast cancer and oral contraceptive use. Am J Epidemiol 1984;119:167-76.

Helmrich SP, Rosenberg L, Kaufman DW, Miller DR, Schottenfeld D, Stolley PD, Shapiro S. Lack of an elevated risk of malignant melanoma in relation to oral contraceptive use. J Natl Cancer Inst 1984;72:617-20.

Shapiro S. The epidemiological evaluation of drugs. Acta Med Scand 1984;683:Suppl:23-7.

Shapiro S, Parsells JL, Rosenberg L, Kaufman DW, Stolley PD, Schottenfeld D. Risk of breast cancer in relation to the use of rauwolfia alkaloids. Eur J Clin Pharmacol 1984;26:143-6.

Kaufman DW, Miller DR, Rosenberg L, Helmrich SP, Stolley PD, Schottenfeld D, Shapiro S. Noncontraceptive estrogen use and the risk of breast cancer. JAMA 1984;252:63-7.

Rosenberg L, Miller DR, Helmrich SP, Kaufman DW, Shapiro S. Breast cancer and coffee drinking. Banbury Report 17: Coffee and Health. Cold Spring Harbor , New York , 1984;189-95.

Miller DR , Rosenberg L, Helmrich SP, Kaufman DW, Shapiro S. Ovarian cancer and coffee drinking. Banbury Report 17: Coffee and Health. Cold Spring Harbor , New York , 1984;157-65.

Helmrich SP, Shapiro S, Rosenberg L, Kaufman DW, Bain C, Miettinen OS, Stolley PD, Rosenshein NB, Knapp RC, Leavitt T, Schottenfeld D, Engle R, Levy M. Risk factors for breast cancer. Am J Epidemiol 1983;117:35-45.

Kaufman DW, Watson J, Rosenberg L, Helmrich SP, Miller DR, Miettinen OS, Stolley PD, Shapiro S. The effect of different types of intrauterine device upon the risk of pelvic inflammatory disease. JAMA 1983;250:759-62.

Rosenberg L, Slone D, Shapiro S, Kaufman DW, Helmrich SP, Miettinen OS, Stolley PD, Levy M, Rosenshein NB, Schottenfeld D, Engle RL. Breast cancer and alcoholic-beverage consumption. Lancet 1982;1:267-70.

Kaufman DW, Slone D, Shapiro S, Rosenberg L, Helmrich SP, Miettinen OS, Stolley PD, Levy M, Schottenfeld D. Diazepam and the risk of breast cancer. Lancet 1982;1:537-9.

Rosenberg L, Shapiro S, Slone D, Kaufman DW, Helmrich SP, Miettinen OS, Stolley PD, Rosenshein NB, Schottenfeld D, Engle RL. Epithelial ovarian cancer and combination oral contraceptives. JAMA 1982;247:3210-12.

Kaufman DW, Shapiro S, Rosenberg L, Monson RR, Miettinen OS, Stolley PD, Slone D. Intrauterine contraceptive device use and pelvic inflammatory disease. Am J Obstet Gynecol 1980;136:159-62.

Kaufman DW, Slone D, Rosenberg L, Miettinen OS, Shapiro S. Cigarette smoking and age at natural menopause. Am J Public Health 1980;70:420-2.

Shapiro S, Kaufman DW, Slone D, Rosenberg L, Miettinen OS, Stolley PD, Rosenshein NB, Watring WG, Leavitt T, Knapp RC. Recent and past use of conjugated estrogens in relation to adenocarcinoma of the endometrium. N Engl J Med 1980;303:485-9.

Rosenberg L, Shapiro S, Slone D, Kaufman DW, Miettinen OS, Stolley PD. Thiazides and acute cholecystitis. N Engl J Med 1980;303:546-8.

Shapiro S, Slone D, Kaufman DW, Rosenberg L, Miettinen OS, Stolley PD, Knapp RC, Leavitt T, Watring WG, Rosenshein NB, Schottenfeld D. Use of thyroid supplements in relation to breast cancer. JAMA 1980;244:1685-7.

Hartz SC, Shapiro S, Kaufman DW, Rosenberg L, Slone D. Factors associated with oral contraceptive use. Am J Public Health 1980;70:1105-8.

Kaufman DW, Shapiro S, Slone D, Rosenberg L, Miettinen OS, Stolley PD, Knapp RC, Leavitt T, Watring WG, Rosenshein NB, Lewis JL, Schottenfeld D, Engle RL. Decreased risk of endometrial cancer among oral-contraceptive users. N Engl J Med 1980;303:1045-7.

Slone D, Shapiro S, Miettinen OS, Finkle WD, Stolley PD. Drug evaluation after marketing. A policy perspective. Ann Intern Med 1979;90:257-61.

Rosenberg L, Shapiro S, Kaufman DW, Slone D, Miettinen OS, Stolley PD. Patterns and determinants of conjugated estrogen use. Am J Epidmiol 1979;109:676-86

Miettinen OS, Slone D, Shapiro S. Current problems in drug-related epidemiologic research. In: Colombo F, Shapiro S, Slone D, Tognoni G, eds. Epidemiological evaluation of drugs. Amsterdam : Elsevier/North Holland Biomedical Press, 1977:295-303.

Shapiro S, Slone D. Case-control surveillance. In: Gross FH, Inman HW, eds. Drug monitoring. London : Academic Press, 1977:33-48.